Zevra Therapeutics: Q1 Earnings Snapshot

Audio By Carbonatix

CELEBRATION, Fla. (AP) — CELEBRATION, Fla. (AP) — Zevra Therapeutics, Inc. (ZVRA) on Wednesday reported a loss of $16.6 million in its first quarter.

The Celebration, Florida-based company said it had a loss of 40 cents per share.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 49 cents per share.

The specialty pharmaceutical company posted revenue of $3.4 million in the period, falling short of Street forecasts. Three analysts surveyed by Zacks expected $3.5 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZVRA at https://www.zacks.com/ap/ZVRA